GlaxoSmithKline Wind Project— 7.5 MW Wind
GlaxoSmithKline Wind Project is a 7.5 MW wind power plant in the United Kingdom, operated by Glaxosmithkline Fao Mr David Bolton. Commissioned in an unspecified year, it contributes to the UK's renewable energy portfolio. Ranked #484 of 819 wind plants in the United Kingdom, this facility's 7.5 MW represents 0.02% of the country's total wind capacity of 30,806 MW. The largest wind plant in the United Kingdom is Hornsea 1 - Heron & Njord at 1,200 MW, making GlaxoSmithKline 160 times smaller. Nearby plants include Hunterston B nuclear power station (965 MW, Nuclear) and Whitelee Wind Farm (539 MW, Wind). The plant is located in Scotland, approximately 50 km from Glasgow.
10 years old
United Kingdom, Europe
- 1,231. largest of 3,024 plants in United Kingdom
- #26,297 worldwide by installed capacity
- #4,544 of 5,731 Wind plants worldwide
10 years in operation
Wind fleet average: 14.4 years
Glaxosmithkline Fao Mr David Bolton operates 1 plants totalling 8 MW
214 plants within 100 km, 8,383 MW combined
Nearest plant: GlaxoSmithKline Wind Project (Turbine 4) (1.1 km)
Location
Zero Direct Emissions
GlaxoSmithKline Wind Project is a wind power plant producing approximately 20 GWh of clean electricity per year with zero direct CO₂ emissions during operation.
Lifecycle emissions: ~11 g CO₂/kWh (manufacturing, transport, decommissioning)
Technical Details
- Primary Fuel Type
- Wind
- Energy Source
- Renewable
- Country
United Kingdom- Continent
- Europe
- Data Source
- Global Power Plant Database
Nearby Power Plants
See Incorrect or Missing Data?
Help us improve our database by reporting any corrections or updates. Your contribution helps keep our global power plant data accurate and up-to-date.